Funding

The Working Group is a non-for profit and informal organization who’s scientific strategy is mainly focused on standardization, validation and development of projects proving the clinical utility of immune-oncology biomarkers, with a current focus on Tumor Infiltrating Lymphocytes.

The Working Group also published guidelines on these topics and develops research projects within this framework. Any funding to help us obtain these goals is greatly appreciated.

If you want to donate to support the Working Group, please contact Roberto Salgado.